Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
Description
Active substance: Clobazam (excl. SUE) The present notice does not concern the award of a public contract within the meaning of the Public Procurement Directive (2014/24/EU) or public procurement cartel law. In the interest of providing as wide an information as possible to interested pharmaceutical enterprises, this notice is published in the Supplement to the Official Journal of the European Union. The procedure designation "Open Procedure" (section IV.1.1) used in the present notice text is due to the requirements of the notice form. Neither this nor the use of the medium "TED" involves any submission to procurement regulations, the application of which is not obligatorily prescribed by law or procurement regulations. This is a framework agreement with an option to join, which relates to various active substances.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Miscellaneous medical devices and products – VE 473.05 105 Deckenversorgungseinheiten Medien
Universitätsklinikum HeidelbergGermanyMiscellaneous medical devices and productsInstallation services of medical equipmentDeadline in 29 daysPublished on Nov 19, 2026
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
BARMER Beschaffung und VergabeGermanyPharmaceutical productsDeadline in 620 daysPublished on Nov 19, 2026
Germany – Medical equipments, pharmaceuticals and personal care products – Absaugung, Invasive Blutdruckmessung und Regionalanästhesie
EK-UNICO GmbHGermanyMedical equipments, pharmaceuticals and personal care productsVenepuncture, blood sampling devicesAnaesthesia and resuscitationDeadline in 32 daysPublished on Nov 19, 2026
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Aflibercept, ausgenommen 114,3 mg/ml (ATC-Code: S01LA05).
AOK Niedersachsen. Die Gesundheitskasse.GermanyPharmaceutical productsDeadline in 707 daysPublished on Nov 19, 2026